The rise of A.D.H.D. diagnoses and prescriptions for stimulants coincided with a remarkably successful two-decade campaign by pharmaceutical companies to publicize the syndrome and promote the pills to doctors, educators and parents. Research by Joseph Biederman, HMS professor of psychiatry at Massachusetts General Hospital, is cited. Aaron Kesselheim, HMS assistant professor of medicine at Brigham and Women’s Hospital, and Tyrone Williams, HMS clinical instructor in psychiatry at Cambridge Health Alliance, are quoted.
News & Research
